ASH China Voice | Prof. Xiaoxia Hu / Dr. Zilu Zhang: IPSS-M and Conditioning Intensity in Transplant Decision-Making for MDS
Allogeneic hematopoietic cell transplantation (allo-HCT) remains the only curative option for patients with myelodysplastic syndromes (MDS). However, clinical decision-making in the transplant setting remains challenging. Two critical and unresolved issues…









